本研究旨在探討台北市三、四級毒品施用者之背景變項、心理韌性、憂鬱與生活滿意度相關性，並且瞭解憂鬱在心理韌性與生活滿意度之間是否存在中介作用。研究對象為112年度02月10日至12月08日期間參與台北市三、四級毒品危害講習者。資料採結構式問卷，包括基本資料、簡易心理韌性量表（BRS）、簡易憂鬱量表（CESD-10）及生活滿意度量表（SWLS）。
研究期間共有308位三、四級毒品施用者，最後266位完整填寫，246位男性（92.5%）、20位女性（7.5%）。研究結果發現（1）參與講習次數與心理韌性呈現正相關；（2）心理韌性與憂鬱呈現負相關；（3）憂鬱和生活滿意度呈現負相關；（4）心理韌性與生活滿意度呈現正相關；（5）憂鬱在心理韌性與生活滿意度之間具有中介效果，且為部分中介。
研究結果顯示三、四級毒品施用者心理韌性、憂鬱及生活滿意度三者間具有顯著相關，建議透過減緩憂鬱及提升心理韌性，促進其生活滿意度，進而改善毒品濫用問題。

Background: This study aims to examine the relationships among background variables, psychological resilience, depression, and life satisfaction in Scheduled III and IV drug offenders in Taipei City. It further explores whether depression serves as a mediator in the relationship between psychological resilience and life satisfaction.

Methods: The participants of this study were individuals who attended Harm Prevention Seminars for Scheduled III and IV drug offenders in Taipei City between February 10 and December 8, 2023. Data were collected using a structured questionnaire, which included demographic information, the Brief Resilience Scale (BRS), the 10-item Center for Epidemiologic Studies Depression Scale (CESD-10), and the Satisfaction with Life Scale (SWLS).

Results: This study involved 308 individuals who used Scheduled III and IV drugs, with 266 completing the survey (92.5% male, 7.5% female). The results showed that the number of seminar attendances was positively correlated with psychological resilience. Psychological resilience was negatively correlated with depression, while depression was negatively correlated with life satisfaction. Additionally, psychological resilience was positively correlated with life satisfaction. Depression was found to partially mediate the relationship between psychological resilience and life satisfaction.

Conclusion: The results of this study indicate significant correlations among psychological resilience, depression, and life satisfaction in individuals using Scheduled III and IV drugs. It is recommended to alleviate depression and enhance psychological resilience in order to promote life satisfaction, which could, in turn, help address issues related to drug abuse.

內政部警政署全球資訊網（2024年1月10日）。112年各月警察機關查獲毒品嫌疑人依毒品級別分。資料引自：https://www.npa.gov.tw/ch/app/data/view?module=wg063&id=2238&serno=11A1078257
行政院 (2016)。新世代反毒策略。資料引自： https://www.ey.gov.tw/Page/5A8A0CB5B41DA11E/47bbd6cf-5762-4a63-a308-b810e84712ce
行政院 (2020)。新世代反毒策略2.0—溯源斷根，毒品零容忍。資料引自：https://www.ey.gov.tw/Page/5A8A0CB5B41DA11E/dd0ee74c-82b9-4b7b-9030-5c2d0869a165
杜維鏌、顏敏琪、吳佳蓉、林梅足、王敏行、陳方、李允白（2017）。簡明復原力量表中文版之信效度研究－以小兒麻痺患者為例。復健諮商，8，1-18。https://www.airitilibrary.com/Article/Detail?DocID=a0000536-201703-201803270009-201803270009-1-18
法務統計資訊網（2024年6月12日）。法務統計年報。資料引自：https://www.rjsd.moj.gov.tw/RJSDWeb/book/Book_Detail.aspx?book_id=642
吳佳儀、洪韡倢（2021）。復原力與自殺防治。自殺防治網通訊，16(4)，11-16。https://doi.org/10.30126/NSPN.202112_16(4).0005
林瑞欽（2006）。三、四級毒品處遇設計與策略研究（計畫編號：p950627）。臺北市：法務部。
林涵雲（2011）。啟動復原力－以復原力觀點運用於敘述諮商。諮商與輔導，304，44-47。https://doi.org/10.29837/CG.201104.0015
林俊杰（2017）。第三、四級毒品犯罪查緝、裁罰與講習成效之質性訪談研究。 藥物濫用防治，2（4），83-107。
毒品危害事件統一裁罰基準及講習辦法（2009）。全國法規資料庫。https://law.moj.gov.tw/LawClass/LawAll.aspx?pcode=I0030025
毒品危害防制條例（2022）。全國法規資料庫。https://law.moj.gov.tw/LawClass/LawAll.aspx?PCode=C0000008
胡海國、畢翠絲（2023）。憂鬱症4問。好心肝，(102)，54-55。https://www.airitilibrary.com/Article/Detail?DocID=P20240429001-N202405210004-00017
黃芷筠（2016）。復原力教育的困境與展望。臺灣教育評論月刊，5(6)，233-235。https://www.airitilibrary.com/Article/Detail?DocID=P20130114001-201606-201606030018-201606030018-233-235
詹中原（2016）。從全球治理論我國毒品防治政策(drug abuse)之機制建構，國政研究報告。
陳順宇（2005）。多變量分析。華泰文化。
Aldridge, J. M., McChesney, K., & Afari, E. (2020). Associations between School Climate and Student Life Satisfaction: Resilience and Bullying as Mediating Factors. Learning Environments Research, 23(1), 129-150. https://doi.org/https://doi.org/10.1007/s10984-019-09296-9
Alswedani, S., Mehmood, R., Katib, I., & Altowaijri, S. M. (2023). Psychological Health and Drugs: Data-Driven Discovery of Causes, Treatments, Effects, and Abuses. Toxics, 11(3), 287. https://doi.org/10.3390/toxics11030287
Aly, S. M., Omran, A., Gaulier, J. M., & Allorge, D. (2020). Substance abuse among children. Archives de Pédiatrie: Organe Officiel de la Société Française de Pédiatrie, 27(8), 480–484. https://doi.org/10.1016/j.arcped.2020.09.006
Anderson, A. S., Siciliano, R. E., Pillai, A., Jiang, W., & Compas, B. E. (2023). Parental drug use disorders and youth psychopathology: Meta-analytic review. Drug and alcohol dependence, 244, 109793. https://doi.org/10.1016/j.drugalcdep.2023.109793
Andresen, E. M., Malmgren, J. A., Carter, W. B., & Patrick, D. L. (1994). Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). American journal of preventive medicine, 10(2), 77–84.
Azman, J., Frković, V., Bilić-Zulle, L., & Petrovecki, M. (2006). Korelacija i regresija [Correlation and regression]. Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 60 Suppl 1, 81–91.
Babic, R., Babic, M., Rastovic, P., Curlin, M., Simic, J., Mandic, K., & Pavlovic, K. (2020). Resilience in Health and Illness. Psychiatria Danubina, 32(Suppl 2), 226–232.
Baron, R. M., & Kenny, D. A. (1986). The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. Journal of personality and social psychology, 51(6), 1173–1182. https://doi.org/10.1037//0022-3514.51.6.1173
Brigitta B. (2002). Pathophysiology of depression and mechanisms of treatment. Dialogues in clinical neuroscience, 4(1), 7–20. https://doi.org/10.31887/DCNS.2002.4.1/bbondy
Boey K. W. (1999). Cross-validation of a short form of the CES-D in Chinese elderly. International journal of geriatric psychiatry, 14(8), 608–617. https://doi.org/10.1002/(sici)1099-1166(199908)14:8<608::aid-gps991>3.0.co;2-z
Bonanno, G. A. (2004). Loss, Trauma, and Human Resilience: Have We Underestimated the Human Capacity to Thrive After Extremely Aversive Events? American Psychologist, 59(1), 20–28. https://doi.org/10.1037/0003-066X.59.1.20
Carmines, E. G., & McIver, J. P. (1981). Analyzing models with unobserved variables: Analysis of covariance structures. In G. W. Bohrnstedt & E. F. Borgatta (Eds.), Social measurement: Current issues (pp. 65–115). Sage Publications.
Cao, Q., & Liang, Y. (2020). Perceived social support and life satisfaction in drug addicts: Self-esteem and loneliness as mediators. Journal of health psychology, 25(7), 976–985. https://doi.org/10.1177/1359105317740620
Cao, Q., & Zhou, Y. (2021). Association between social support and life satisfaction among people with substance use disorder: the mediating role of resilience. Journal of ethnicity in substance abuse, 20(3), 415–427. https://doi.org/10.1080/15332640.2019.1657545
Chang, Y. H., Yang, C. T., & Hsieh, S. (2023). Social support enhances the mediating effect of psychological resilience on the relationship between life satisfaction and depressive symptom severity. Scientific reports, 13(1), 4818. https://doi.org/10.1038/s41598-023-31863-7
Cheung, G. W., & Lau, R. S. (2008). Testing mediation and suppression effects of latent variables: Bootstrapping with structural equation models. Organizational Research Methods, 11(2), 296–325. https://doi.org/10.1177/1094428107300343
Cheung, G. W., & Lau, R. S. (2012). A direct comparison approach for testing measurement invariance. Organizational Research Methods, 15(2), 167–198. https://doi.org/10.1177/1094428111421987
Cheung, N. W., Cheung, Y. W., & Chen, X. (2016). Permissive Attitude Towards Drug Use, Life Satisfaction, and Continuous Drug Use Among Psychoactive Drug Users in Hong Kong. East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists , 26(2), 60–69.
Chien, C. P., & Cheng, T. A. (1985). Depression in Taiwan: epidemiological survey utilizing CES-D. Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 87(5), 335–338.
Chmitorz, A., Kunzler, A., Helmreich, I., Tüscher, O., Kalisch, R., Kubiak, T., Wessa, M., & Lieb, K. (2018). Intervention studies to foster resilience - A systematic review and proposal for a resilience framework in future intervention studies. Clinical psychology review, 59, 78–100. https://doi.org/10.1016/j.cpr.2017.11.002
Ciuca Anghel, D. M., Nițescu, G. V., Tiron, A. T., Guțu, C. M., & Baconi, D. L. (2023). Understanding the Mechanisms of Action and Effects of Drugs of Abuse. Molecules (Basel, Switzerland), 28(13), 4969. https://doi.org/10.3390/molecules28134969
Cladder-Micus, M. B., Speckens, A. E. M., Vrijsen, J. N., T Donders, A. R., Becker, E. S., & Spijker, J. (2018). Mindfulness-based cognitive therapy for patients with chronic, treatment-resistant depression: A pragmatic randomized controlled trial. Depression and anxiety, 35(10), 914–924. https://doi.org/10.1002/da.22788
Cuijpers, P., Quero, S., Dowrick, C., & Arroll, B. (2019). Psychological Treatment of Depression in Primary Care: Recent Developments. Current psychiatry reports, 21(12), 129. https://doi.org/10.1007/s11920-019-1117-x
Dallas, J. C., Jullamate, P., Vatanasin, D., Moungkum, S., Nadarajan, S., & Krungkraipetch, N. (2023). Resilience and Influencing Factors Among Youths Undergoing Substance Abuse Treatment in Thailand: A Cross-Sectional Study. SAGE open nursing, 9, 23779608231157986. https://doi.org/10.1177/23779608231157986
Davis, L., Uezato, A., Newell, J. M., & Frazier, E. (2008). Major depression and comorbid substance use disorders. Current opinion in psychiatry, 21(1), 14–18. https://doi.org/10.1097/YCO.0b013e3282f32408
Diener, E., Emmon, R.A., Larson, R.J. & Griffin, S. (1985). The satisfaction with life scales. Journal of Personality Assessment, 49(1), 71-75. https://doi.org/10.1207/s15327752jpa4901_13
DuPont, R. L., Han, B., Shea, C. L., & Madras, B. K. (2018). Drug use among youth: National survey data support a common liability of all drug use. Preventive medicine, 113, 68–73. https://doi.org/10.1016/j.ypmed.2018.05.015
El Rawas, R., Amaral, I. M., & Hofer, A. (2020). Social interaction reward: A resilience approach to overcome vulnerability to drugs of abuse. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 37, 12–28. https://doi.org/10.1016/j.euroneuro.2020.06.008
Fergusson, D. M., McLeod, G. F., Horwood, L. J., Swain, N. R., Chapple, S., & Poulton, R. (2015). Life satisfaction and mental health problems (18 to 35 years). Psychological medicine, 45(11), 2427–2436. https://doi.org/10.1017/S0033291715000422
Ferigolo, M., Stein, A. T., Fuchs, F. D., & Barros, H. M. (2009). Influence of depression and early adverse experiences on illicit drug dependence: a case-control study. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 31(2), 106–113. https://doi.org/10.1590/s1516-44462009000200005
Garofoli M. (2020). Adolescent Substance Abuse. Primary care, 47(2), 383–394. https://doi.org/10.1016/j.pop.2020.02.013
Horowitz S. (2009). Effect of Positive Emotions on Health: Hope and Humor. Alternative and Complementary Therapies, 15 (4), 196-202. https://doi.org/10.1089/act.2009.15706
Hu, L., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling: A Multidisciplinary Journal, 6(1), 1–55. https://doi.org/10.1080/10705519909540118
Imran, A., Tariq, S., Kapczinski, F., & de Azevedo Cardoso, T. (2024). Psychological resilience and mood disorders: a systematic review and meta-analysis. Trends in psychiatry and psychotherapy, 46, e20220524. https://doi.org/10.47626/2237-6089-2022-0524
Kachouie, N. N., & Deebani, W. (2020). Association Factor for Identifying Linear and Nonlinear Correlations in Noisy Conditions. Entropy (Basel, Switzerland), 22(4), 440. https://doi.org/10.3390/e22040440
Kaiser, T., Hennecke, M., & Luhmann, M. (2020). The interplay of domain-and life satisfaction in predicting life events. PloS one, 15(9), e0238992. https://doi.org/10.1371/journal.pone.0238992
Kang W. (2023). Illegal drug use is associated with poorer life satisfaction and self-rated health (SRH) in young people. Frontiers in psychiatry, 14, 955626. https://doi.org/10.3389/fpsyt.2023.955626
Kaya-Akyüzlü, D., Ozkan-Kotiloglu, S., Yıldırım, S. A., Danışman, M., Yıldırım, M. A., & Ozgür-Ilhan, I. (2024). Effect of MAOA rs1465108 polymorphism on susceptibility to substance/alcohol use disorder: A novel PCR-RFLP assay for the detection of MAOA rs1465108. Molecular Biology Reports, 51(1), 400. https://doi.org/10.1007/s11033-024-09366-z
Kendler, K. S., Ohlsson, H., Clouston, S., Fagan, A. A., Sundquist, J., & Sundquist, K. (2021). The causal effect of resilience on risk for drug abuse: A Swedish national instrumental variable, co-relative and propensity-score analysis. Psychological Medicine, 51(5), 846–852. https://doi.org/10.1017/S0033291719003842
Kirby T. (2015). Ketamine for depression: the highs and lows. The lancet. Psychiatry, 2(9), 783–784. https://doi.org/10.1016/S2215-0366(15)00392-2
Krentzman A. R. (2013). Review of the application of positive psychology to substance use, addiction, and recovery research. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors, 27(1), 151–165. https://doi.org/10.1037/a0029897
Kusier, A. O., & Folker, A. P. (2021). The Satisfaction with Life Scale: Philosophical Foundation and Practical Limitations. Health care analysis : HCA : journal of health philosophy and policy, 29(1), 21–38. https://doi.org/10.1007/s10728-020-00420-y
Lee, D., Delcher, C., Maldonado-Molina, M. M., Thogmartin, J. R., & Goldberger, B. A. (2016). Manners of Death in Drug-Related Fatalities in Florida. Journal of forensic sciences, 61(3), 735–742. https://doi.org/10.1111/1556-4029.12999
Lee, T. S., Liu, Y. H., Huang, Y. J., Tang, W. K., Wang, Y., Hu, S., Lin, C. P., Li, C. R., & Hung, C. C. (2022). Clinical and behavior characteristics of individuals who used ketamine. Scientific reports, 12(1), 801. https://doi.org/10.1038/s41598-022-04832-9
Leshner A. I. (1997). Addiction is a brain disease, and it matters. Science (New York, N.Y.), 278(5335), 45–47. https://doi.org/10.1126/science.278.5335.45
Link, B. G., Struening, E. L., Rahav, M., Phelan, J. C., & Nuttbrock, L. (1997). On stigma and its consequences: evidence from a longitudinal study of men with dual diagnoses of mental illness and substance abuse. Journal of health and social behavior, 38(2), 177–190.
Lima, T. M., Visacri, M. B., & Aguiar, P. M. (2022). Use of ketamine and esketamine for depression: an overview of systematic reviews with meta-analyses. European journal of clinical pharmacology, 78(3), 311–338. https://doi.org/10.1007/s00228-021-03216-8
Lo, T. W., Yeung, J. W. K., & Tam, C. H. L. (2020). Substance Abuse and Public Health: A Multilevel Perspective and Multiple Responses. International journal of environmental research and public health, 17(7), 2610. https://doi.org/10.3390/ijerph17072610
Loo C. (2018). Can we confidently use ketamine as a clinical treatment for depression?. The lancet. Psychiatry, 5(1), 11–12. https://doi.org/10.1016/S2215-0366(17)30480-7
Luthar, S. S., Cicchetti, D., & Becker, B. (2000). The construct of resilience: a critical evaluation and guidelines for future work. Child development, 71(3), 543–562. https://doi.org/10.1111/1467-8624.00164
Luo, D., Tan, L., Shen, D., Gao, Z., Yu, L., Lai, M., Xu, J., & Li, J. (2022). Characteristics of depression, anxiety, impulsivity, and aggression among various types of drug users and factors for developing severe depression: a cross-sectional study. BMC psychiatry, 22(1), 274. https://doi.org/10.1186/s12888-022-03933-z
Marchi, M., Magarini, F. M., Galli, G., Mordenti, F., Travascio, A., Uberti, D., De Micheli, E., Pingani, L., Ferrari, S., & Galeazzi, G. M. (2022). The effect of ketamine on cognition, anxiety, and social functioning in adults with psychiatric disorders: A systematic review and meta-analysis. Frontiers in neuroscience, 16, 1011103. https://doi.org/10.3389/fnins.2022.1011103
Masanda A. B. (2024). Positive Psychology Intervention (PPI) Program for Persons Who Use Drugs (PWUDS): A Pilot Study. Journal of primary care & community health, 15, 21501319241271909. https://doi.org/10.1177/21501319241271909
Milovanska-Farrington, S., & Farrington, S. (2022). Happiness, domains of life satisfaction, perceptions, and valuation differences across genders. Acta psychologica, 230, 103720. https://doi.org/10.1016/j.actpsy.2022.103720
Moe, F. D., Erga, A., Bjornestad, J., & Dettweiler, U. (2024). The interdependence of substance use, satisfaction with life, and psychological distress: a dynamic structural equation model analysis. Frontiers in psychiatry, 15, 1288551. https://doi.org/10.3389/fpsyt.2024.1288551
Pan, W. H., Wu, K. C., Chen, C. Y., Chu, Y. R., Wu, S. C., Jou, S., Lu, T. P., Tung, Y. C., Hsu, J., & Chen, W. J. (2021). First-time offenders for recreational ketamine use under a new penalty system in Taiwan: incidence, recidivism and mortality in national cohorts from 2009 to 2017. Addiction (Abingdon, England), 116(7), 1770–1781.
Pastor, A., Conn, J., MacIsaac, R. J., & Bonomo, Y. (2020). Alcohol and illicit drug use in people with diabetes. Lancet Diabetes & Endocrinology, 8, 239–248. doi: 10.1016/s2213-8587(19)30410-3
Pavot, W., & Diener, E. (2008). The Satisfaction With Life Scale and the emerging construct of life satisfaction. Journal of Positive Psychology, 3, 137–152. https://doi.org/10.1080/17439760701756946.
Pripp, A. H. (2018). Pearson's or Spearman's correlation coefficients. Tidsskrift for den Norske Laegeforening: Tidsskrift for praktisk medicin, ny raekke, 138(8). https://doi.org/10.4045/tidsskr.18.0042
Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401. https://doi.org/10.1177/014662167700100306
Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) Study. JAMA, 264(19), 2511–2518. https://doi.org/10.1001/jama.1990.03450190043026
Reynaldo, J. A., & Santos, A. (1999). Cronbach’s alpha: A tool for assessing the reliability of scales. Journal of Extension, 37(2), 1–4. https://doi.org/10.4236/psych.2011.21008
Rogeberg, O., & Pedersen, W. (2021). Help-seeking behaviour among illegal substance users. Tidsskrift for den Norske Laegeforening: Tidsskrift for praktisk medicin, ny raekke, 141(9). https://doi.org/10.4045/tidsskr.21.0249
Rossow, I., & Lauritzen, G. (1999). Balancing on the edge of death: Suicide attempts and life-threatening overdoses among drug addicts. Addiction, 94(2), 209–219. https://doi.org/10.1046/j.1360-0443.1999.9422095.x
Rudzinski, K., McDonough, P., Gartner, R., & Strike, C. (2017). Is there room for resilience? A scoping review and critique of substance use literature and its utilization of the concept of resilience. Substance abuse treatment, prevention, and policy, 12(1), 41. https://doi.org/10.1186/s13011-017-0125-2
Ruhwinkel, B., & Buchmann, M. (2022). Resilienz, ein Modewort? [Resilience, a Buzzword?]. Praxis, 111(14), 793–796. https://doi.org/10.1024/1661-8157/a003920
Salmanzadeh, H., Ahmadi-Soleimani, S. M., Azadi, M., Halliwell, R. F., & Azizi, H. (2021). Adolescent Substance Abuse, Transgenerational Consequences and Epigenetics. Current neuropharmacology, 19(9), 1560–1569. https://doi.org/10.2174/1570159X19666210303121519
Sarris, J., O'Neil, A., Coulson, C. E., Schweitzer, I., & Berk, M. (2014). Lifestyle medicine for depression. BMC psychiatry, 14, 107. https://doi.org/10.1186/1471-244X-14-107
Schrank, B., Brownell, T., Tylee, A., & Slade, M. (2014). Positive psychology: an approach to supporting recovery in mental illness. East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan, 24(3), 95–103.
Seligman, M. E. P. (1999). The President’s Address.
American Psychologist, 54(8), 559-562.
Seligman, M. E. P. (1999). The President’s Address.
American Psychologist, 54(8), 559-562.
Seligman, M. E. P. (1999). The President’s Address.
American Psychologist, 54(8), 559-562.
Seligman, M. E. P. (1998). The president’s address. American Psychologist, 54(8), 559-562.
Seligman, M. E. P., & Csikszentmihalyi, M. (2014). Positive psychology: An introduction. In M. Csikszentmihalyi (Ed.), Flow and the Foundations of Positive Psychology (pp. 279-298). Dordrecht: Springer.
Sin, N. L., & Lyubomirsky, S. (2009). Enhancing well-being and alleviating depressive symptoms with positive psychology interventions: a practice-friendly meta-analysis. Journal of clinical psychology, 65(5), 467–487. https://doi.org/10.1002/jclp.20593
Smith, B., Dalen, J., Wiggins, K., Tooley, E., Christopher, P., & Bernard, J. (2008). The Brief Resilience Scale: Assessing the ability to bounce back. International Journal of Behavioral Medicine, 15(3), 194-200. https://doi.org/10.1080/10705500802222972
Stellern, J., Xiao, K. B., Grennell, E., Sanches, M., Gowin, J. L., & Sloan, M. E. (2023). Emotion regulation in substance use disorders: a systematic review and meta-analysis. Addiction (Abingdon, England), 118(1), 30–47. https://doi.org/10.1111/add.16001
Su, T. P., Chen, M. H., Li, C. T., Lin, W. C., Hong, C. J., Gueorguieva, R., Tu, P. C., Bai, Y. M., Cheng, C. M., & Krystal, J. H. (2017). Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 42(13), 2482–2492. https://doi.org/10.1038/npp.2017.94
Swimmer, K. R., & Sandelich, S. (2024). Substance Use Disorder. Emergency medicine clinics of North America, 42(1), 53–67. https://doi.org/10.1016/j.emc.2023.06.023
Troy, A. S., Willroth, E. C., Shallcross, A. J., Giuliani, N. R., Gross, J. J., & Mauss, I. B. (2023). Psychological Resilience: An Affect-Regulation Framework. Annual review of psychology, 74, 547–576. https://doi.org/10.1146/annurev-psych-020122-041854
United Nations Office on Drugs and Crime. (2023). World Drug Report 2023. Retrieved from https://www.unodc.org/unodc/en/newyork/events/world-drug-report-2023-ny.html
United Nations Office on Drugs and Crime. (2024). World Drug Report 2024. Retrieved from https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2024.html
Volkow, N. D., & Boyle, M. (2018). Neuroscience of Addiction: Relevance to Prevention and Treatment. The American journal of psychiatry, 175(8), 729–740. https://doi.org/10.1176/appi.ajp.2018.17101174
Waller, M. A. (2001). Resilience in ecosystemic context: Evolution of the concept. American Journal of Orthopsychiatry, 71, 290-297. https://doi.org/10.1037/0002-9432.71.3.290
World Health Organization.(1946). Preamble to the Constitution of World Health Organization as adopted by the International Health Conference. New York:World Health Organization.
World Health Organization. (1988) . Ethical criteria for medicinal drug promotion. Geneva : World Health Organization.
Wu, C. H., & Yao, G. (2006). Analysis of factorial invariance across gender in the Taiwan version of the Satisfaction with Life Scale. Personality and Individual Differences, 40, 1259-1268. doi: 10.1016/ j.paid.2005.11.012
Yadid, G., Ahdoot-Levi, H., Bareli, T., Maayan, R., & Weizman, A. (2018). Dehydroepiandrosterone and Addiction. Vitamins and hormones, 108, 385–412. https://doi.org/10.1016/bs.vh.2018.04.001
Yang, C., Zhou, Y., & Xia, M. (2020). How Resilience Promotes Mental Health of Patients With DSM-5 Substance Use Disorder? The Mediation Roles of Positive Affect, Self-Esteem, and Perceived Social Support. Frontiers in psychiatry, 11, 588968. https://doi.org/10.3389/fpsyt.2020.588968
Zhang, S., Wu, S., Wu, Q., Durkin, D. W., & Marsiglia, F. F. (2021). Adolescent drug use initiation and transition into other drugs: A retrospective longitudinal examination across race/ethnicity. Addictive behaviors, 113, 106679. https://doi.org/10.1016/j.addbeh.2020.106679